Literature DB >> 17936361

Sub-cellular localization of manganese in the basal ganglia of normal and manganese-treated rats An electron spectroscopy imaging and electron energy-loss spectroscopy study.

M Morello1, A Canini, P Mattioli, R P Sorge, A Alimonti, B Bocca, G Forte, A Martorana, G Bernardi, G Sancesario.   

Abstract

We have studied at the ultrastructural level the presence of manganese (Mn) in rat basal ganglia, which are target regions of the brain for Mn toxicity. The rats underwent a moderate level of Mn exposure induced per os for 13 weeks. Mn was detected by means of electron spectroscopy imaging (ESI) and electron energy-loss spectroscopy (EELS) analyses on perfusion fixed samples embedded in resin. While no significant contamination by exogenous Mn occurred during the processing procedures, less than 50% of endogenous Mn was lost during fixation and dehydration of the brain samples. The residual Mn ions in the samples appeared as discrete particles, localized in selected sub-cellular organelles in a cell, suggesting that no significant translocation had occurred in the surrounding area. In control rats, the Mn sub-cellular localization and relative content were the same in neurons and astrocytes of rat striatum and globus pallidus: the Mn level was highest in the heterochromatin and in the nucleolus, intermediate in the cytoplasm, and lowest in the mitochondria (p<0.001). After chronic Mn treatment, while no ultrastructural damage was detected in the neurons and glial cells, the largest rate of Mn increase was noted in the mitochondria of astrocytes (+700%), an intermediate rate in the mitochondria of neurons (+200%), and the lowest rate in the nuclei (+100%) of neurons and astrocytes; the Mn level in the cytoplasm appeared unchanged. EELS analysis detected the specific spectra of Mn L(2,3) (peak at DeltaE = 665 eV) in such organelles, confirming the findings of ESI. Although a consistent loss of Mn occurred during the processing of tissue samples, ESI and EELS can be useful methods for localization of endogenous Mn in embedded tissues. The high rate of Mn sequestration in the mitochondria of astrocytes in vivo may partly explain the outstanding capacity of astrocytes to accumulate Mn, and their early dysfunction in Mn neurotoxicity. The high level of Mn in the heterochromatin and nucleoli of neurons and astrocytes in basal conditions and its further increase after Mn overload should provide insight into new avenues of investigating the role of Mn in the normal brain and a baseline for future Mn toxicity studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17936361     DOI: 10.1016/j.neuro.2007.09.001

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  42 in total

1.  β-Cell subcellular localization of glucose-stimulated Mn uptake by X-ray fluorescence microscopy: implications for pancreatic MRI.

Authors:  Lara Leoni; Anita Dhyani; Patrick La Riviere; Stefan Vogt; Barry Lai; B B Roman
Journal:  Contrast Media Mol Imaging       Date:  2011 Nov-Dec       Impact factor: 3.161

Review 2.  Role of manganese in neurodegenerative diseases.

Authors:  Aaron B Bowman; Gunnar F Kwakye; Elena Herrero Hernández; Michael Aschner
Journal:  J Trace Elem Med Biol       Date:  2011-10-01       Impact factor: 3.849

3.  Manganese accumulates within golgi apparatus in dopaminergic cells as revealed by synchrotron X-ray fluorescence nanoimaging.

Authors:  Asunción Carmona; Guillaume Devès; Stéphane Roudeau; Peter Cloetens; Sylvain Bohic; Richard Ortega
Journal:  ACS Chem Neurosci       Date:  2009-12-17       Impact factor: 4.418

4.  X-ray fluorescence imaging of the hippocampal formation after manganese exposure.

Authors:  Gregory Robison; Taisiya Zakharova; Sherleen Fu; Wendy Jiang; Rachael Fulper; Raul Barrea; Wei Zheng; Yulia Pushkar
Journal:  Metallomics       Date:  2013-11       Impact factor: 4.526

5.  Manganese accumulates primarily in nuclei of cultured brain cells.

Authors:  Kiran Kalia; Wendy Jiang; Wei Zheng
Journal:  Neurotoxicology       Date:  2008-03-06       Impact factor: 4.294

6.  Fluoxetine and Riluzole Mitigates Manganese-Induced Disruption of Glutamate Transporters and Excitotoxicity via Ephrin-A3/GLAST-GLT-1/Glu Signaling Pathway in Striatum of Mice.

Authors:  Zhipeng Qi; Xinxin Yang; Yanqi Sang; Yanan Liu; Jiashuo Li; Bin Xu; Wei Liu; Miao He; Zhaofa Xu; Yu Deng; Jinghai Zhu
Journal:  Neurotox Res       Date:  2020-05-29       Impact factor: 3.911

7.  Age-dependent susceptibility to manganese-induced neurological dysfunction.

Authors:  Julie A Moreno; Elizabeth C Yeomans; Karin M Streifel; Bryan L Brattin; Robert J Taylor; Ronald B Tjalkens
Journal:  Toxicol Sci       Date:  2009-10-07       Impact factor: 4.849

8.  Manganese-induced Mitochondrial Dysfunction Is Not Detectable at Exposures Below the Acute Cytotoxic Threshold in Neuronal Cell Types.

Authors:  Emily B Warren; Miles R Bryan; Patricia Morcillo; Keisha N Hardeman; Michael Aschner; Aaron B Bowman
Journal:  Toxicol Sci       Date:  2020-08-01       Impact factor: 4.849

Review 9.  Role of transcription factor yin yang 1 in manganese-induced reduction of astrocytic glutamate transporters: Putative mechanism for manganese-induced neurotoxicity.

Authors:  Pratap Karki; Keisha Smith; James Johnson; Michael Aschner; Eunsook Lee
Journal:  Neurochem Int       Date:  2014-08-13       Impact factor: 3.921

10.  A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease.

Authors:  Andrew M Tidball; Miles R Bryan; Michael A Uhouse; Kevin K Kumar; Asad A Aboud; Jack E Feist; Kevin C Ess; M Diana Neely; Michael Aschner; Aaron B Bowman
Journal:  Hum Mol Genet       Date:  2014-12-08       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.